BIODESIX, INC. Interest Expense
BIODESIX, INC. (BDSX) reported Interest Expense of $1.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-05
- BIODESIX, INC. interest expense for the quarter ending 2026-06-30 was $1.98M, a 4.43% increase year-over-year.
- BIODESIX, INC. interest expense for the quarter ending 2026-03-31 was $1.98M, a 17.33% increase year-over-year.
- BIODESIX, INC. interest expense for the quarter ending 2025-12-31 was $2.06M, a 17.52% increase year-over-year.
- BIODESIX, INC. interest expense for the quarter ending 2025-09-30 was $2.07M, a 1.62% increase year-over-year.
- BIODESIX, INC. interest expense for fiscal 2025 was $7.72M, a 6.56% decline from fiscal 2024.
- BIODESIX, INC. interest expense for fiscal 2024 was $8.26M, a 13.40% decline from fiscal 2023.
- BIODESIX, INC. interest expense for fiscal 2023 was $9.54M, a 18.14% increase from fiscal 2022.
- BIODESIX, INC. interest expense for fiscal 2022 was $8.07M, a 79.06% increase from fiscal 2021.
| Period end | Interest Expense 2 month | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.98M 10-Q · filed 2026-08-05 | $3.96M 10-Q · filed 2026-08-05 | $6.02M derived: sum of 3 quarters · filed 2026-08-05 | $8.09M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $1.98M 10-Q · filed 2026-05-04 | $4.04M derived: sum of 2 quarters · filed 2026-05-04 | $6.11M derived: sum of 3 quarters · filed 2026-05-04 | $8.01M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.13M derived: sum of 2 quarters · filed 2026-02-26 | $6.03M derived: sum of 3 quarters · filed 2026-08-05 | $7.72M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $2.07M 10-Q · filed 2025-11-03 | $3.97M derived: sum of 2 quarters · filed 2026-08-05 | $5.66M 10-Q · filed 2025-11-03 | $7.41M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $1.90M 10-Q · filed 2026-08-05 | $3.58M 10-Q · filed 2026-08-05 | $5.33M derived: sum of 3 quarters · filed 2026-08-05 | $7.38M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $1.69M 10-Q · filed 2026-05-04 | $3.44M derived: sum of 2 quarters · filed 2026-05-04 | $5.48M derived: sum of 3 quarters · filed 2026-05-04 | $7.41M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.79M derived: sum of 2 quarters · filed 2026-02-26 | $5.73M derived: sum of 3 quarters · filed 2026-02-26 | $8.26M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $2.04M 10-Q · filed 2025-11-03 | $3.98M derived: sum of 2 quarters · filed 2025-11-03 | $6.51M 10-Q · filed 2025-11-03 | $8.83M derived: sum of 4 quarters · filed 2025-11-03 | ||
| 2024-06-30 | $1.94M 10-Q · filed 2025-08-07 | $1.94M 10-Q · filed 2024-08-07 | $4.46M 10-Q · filed 2025-08-07 | $6.79M derived: sum of 3 quarters · filed 2025-08-07 | $9.18M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $2.53M 10-Q · filed 2025-05-13 | $4.86M derived: sum of 2 quarters · filed 2025-05-13 | $7.24M derived: sum of 3 quarters · filed 2025-05-13 | $9.67M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $4.71M derived: sum of 2 quarters · filed 2025-03-03 | $7.14M derived: sum of 3 quarters · filed 2025-03-03 | $9.54M 10-K · filed 2025-03-03 | ||
| 2023-09-30 | $2.39M 10-Q · filed 2023-11-07 | $4.82M derived: sum of 2 quarters · filed 2024-08-07 | $7.21M 10-Q · filed 2023-11-07 | $9.76M derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-06-30 | $2.43M 10-Q · filed 2024-08-07 | $4.82M 10-Q · filed 2024-08-07 | $7.37M derived: sum of 3 quarters · filed 2024-08-07 | $10.41M derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | $2.39M 10-Q · filed 2024-05-08 | $4.94M derived: sum of 2 quarters · filed 2024-05-08 | $7.98M derived: sum of 3 quarters · filed 2024-05-08 | $9.33M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $5.59M derived: sum of 2 quarters · filed 2024-03-01 | $6.93M derived: sum of 3 quarters · filed 2024-03-01 | $8.07M 10-K · filed 2024-03-01 | ||
| 2022-09-30 | $3.04M 10-Q · filed 2023-11-07 | $4.38M derived: sum of 2 quarters · filed 2023-11-07 | $5.52M 10-Q · filed 2023-11-07 | $7.02M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $100.00K 10-Q · filed 2022-08-04 | $1.35M 10-Q · filed 2023-08-07 | $2.48M 10-Q · filed 2023-08-07 | $3.98M derived: sum of 3 quarters · filed 2023-08-07 | $5.53M derived: sum of 4 quarters · filed 2023-08-07 | |
| 2022-03-31 | $1.14M 10-Q · filed 2023-05-11 | $2.63M derived: sum of 2 quarters · filed 2023-05-11 | $4.18M derived: sum of 3 quarters · filed 2023-05-11 | $4.99M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.04M derived: sum of 2 quarters · filed 2023-03-06 | $3.86M derived: sum of 3 quarters · filed 2023-03-06 | $4.51M 10-K · filed 2023-03-06 | ||
| 2021-09-30 | $1.55M 10-Q · filed 2022-11-03 | $2.36M derived: sum of 2 quarters · filed 2022-11-03 | $3.01M 10-Q · filed 2022-11-03 | $3.72M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $815.00K 10-Q · filed 2022-08-04 | $1.47M 10-Q · filed 2022-08-04 | $2.17M derived: sum of 3 quarters · filed 2022-08-04 | $4.83M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $651.00K 10-Q · filed 2022-05-11 | $1.36M derived: sum of 2 quarters · filed 2022-05-11 | $4.01M derived: sum of 3 quarters · filed 2022-05-11 | $6.80M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $3.36M derived: sum of 2 quarters · filed 2022-03-14 | $6.15M derived: sum of 3 quarters · filed 2022-03-14 | $7.60M 10-K · filed 2022-03-14 | ||
| 2020-09-30 | $2.66M 10-Q · filed 2021-11-15 | $5.44M derived: sum of 2 quarters · filed 2021-11-15 | $6.90M 10-Q · filed 2021-11-15 | $7.90M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $2.78M 10-Q · filed 2021-08-10 | $4.24M 10-Q · filed 2021-08-10 | $5.24M derived: sum of 3 quarters · filed 2021-08-10 | $5.95M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $1.46M 10-Q · filed 2021-05-11 | $2.46M derived: sum of 2 quarters · filed 2021-05-11 | $3.17M derived: sum of 3 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.71M derived: sum of 2 quarters · filed 2021-03-16 | $3.01M 10-K · filed 2021-03-16 | |||
| 2019-09-30 | $706.00K 10-Q · filed 2020-12-10 | $2.00M 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |